{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:08:29Z","timestamp":1761235709468},"reference-count":15,"publisher":"Hindawi Limited","issue":"1","license":[{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1034\/j.1600-0404.2003.00179.x","type":"journal-article","created":{"date-parts":[[2004,12,18]],"date-time":"2004-12-18T22:55:18Z","timestamp":1103410518000},"page":"71-74","source":"Crossref","is-referenced-by-count":38,"title":["Serum tumour necrosis factor-\u03b1 and soluble tumour necrosis factor receptors levels in patients with Guillain-Barre syndrome"],"prefix":"10.1155","volume":"109","author":[{"given":"V. V.","family":"Radhakrishnan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. G.","family":"Sumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Reuben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mathai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. D.","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2003,10,1]]},"reference":[{"key":"10.1034\/j.1600-0404.2003.00179.x-BIB1|cit2","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/mus.880150506","article-title":"Sural nerve biopsies in Guillain-Barre syndrome; axonal degeneration and macrophages, associated demyelination and absence of cytomegalovirus genome","volume":"0","author":"Hughes","year":"1992","journal-title":"Muscle Nerve"},{"key":"10.1034\/j.1600-0404.2003.00179.x-BIB2|cit3","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/(SICI)1097-4598(199604)19:4<474::AID-MUS8>3.0.CO;2-9","article-title":"Inflammatory infiltrates in sural nerve biopsies in Guillain-Barre syndrome and chronic inflammatory demyelinating neuropathy","volume":"19","author":"Schmidt","year":"1996","journal-title":"Muscle Nerve"},{"key":"10.1034\/j.1600-0404.2003.00179.x-BIB3|cit4","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/ana.410380516","article-title":"Anti-ganglioside GM1 antibodies in Guillain-Barre syndrome and their relationship to Campylobacter jejuni infection","volume":"38","author":"Rees","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1034\/j.1600-0404.2003.00179.x-BIB4|cit5","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/ana.410330606","article-title":"Elevated serum levels of tumour necrosis factor alpha in Guillain-Barre syndrome","volume":"33","author":"Sharief","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1034\/j.1600-0404.2003.00179.x-BIB5|cit6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ana.410230405","article-title":"Tumour necrosis factor mediates myelin and oligodendrocyte damage in-vitro","volume":"23","author":"Selmaj","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1034\/j.1600-0404.2003.00179.x-BIB6|cit7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barre syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1034\/j.1600-0404.2003.00179.x-BIB7|cit8","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","article-title":"Controlled trial of prednisolone in acute polyneuropathy","volume":"2","author":"Hughes","year":"1978","journal-title":"Lancet"},{"key":"10.1034\/j.1600-0404.2003.00179.x-BIB8|cit9","doi-asserted-by":"crossref","first-page":"14927","DOI":"10.1016\/S0021-9258(18)63791-3","article-title":"Two different cell type have different major receptors for human tumour necrosis factor alpha","volume":"264","author":"Hohmann","year":"1984","journal-title":"J Biol Chem"},{"key":"10.1034\/j.1600-0404.2003.00179.x-BIB9|cit10","first-page":"221","article-title":"Tumour necrosis factor; receptors and inhibitors","volume":"3","author":"Loetscher","year":"1991","journal-title":"Cancer Cells"},{"key":"10.1034\/j.1600-0404.2003.00179.x-BIB10|cit11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1084\/jem.175.2.323","article-title":"Stabilization of the bioactivity of human tumour necrosis factor by its soluble receptors","volume":"175","author":"Aderka","year":"1992","journal-title":"J Exp Med"},{"key":"10.1034\/j.1600-0404.2003.00179.x-BIB11|cit12","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1212\/WNL.52.9.1833","article-title":"Immunoglobulin reduces circulating proinflammatory cytokines in Guillain-Barre syndrome","volume":"52","author":"Sharief","year":"1999","journal-title":"Neurology"},{"key":"10.1034\/j.1600-0404.2003.00179.x-BIB12|cit13","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1212\/WNL.58.3.476","article-title":"Non-TH 1 cytokines are augmented systematically early in Guillain-Barre syndrome","volume":"58","author":"Press","year":"2002","journal-title":"Neurology"},{"key":"10.1034\/j.1600-0404.2003.00179.x-BIB13|cit14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1468-1331.2000.00005.x","article-title":"Expression of TNF and TGF1 in Guillain-Barre syndrome: correlation of a low TNF-\/TGF1-mRNA ratio with good recovery and signs for immunoregulation within the cerebrospinal fluid compartment","volume":"7","author":"Ossege","year":"2000","journal-title":"Eur J Neurol"},{"key":"10.1034\/j.1600-0404.2003.00179.x-BIB14|cit15","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ana.410440517","article-title":"Genetic contribution of tumor necrosis factor region in Guillain-Barre syndrome","volume":"44","author":"Ma","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1034\/j.1600-0404.2003.00179.x-BIB15|cit16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0165-5728(96)00075-6","article-title":"Circulating tumour necrosis factor alpha (TNFa) and soluble TNF factors in patients with Guillain-Barre Syndrome","volume":"68","author":"Creange","year":"1996","journal-title":"J Neuroimmunol"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0404.2003.00179.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0404.2003.00179.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1034\/j.1600-0404.2003.00179.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:41:45Z","timestamp":1671540105000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1034\/j.1600-0404.2003.00179.x"}},"subtitle":["<b>TNF-\u03b1 and TNF-receptors in GBS<\/b>"],"short-title":[],"issued":{"date-parts":[[2003,10,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"URL":"https:\/\/doi.org\/10.1034\/j.1600-0404.2003.00179.x","archive":["Portico"],"relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2003,10,1]]}}}